Piramal Pharma

248.75
-1.85
(-0.74%)
Market Cap (₹ Cr.)
₹33,250
52 Week High
307.90
Book Value
₹60
52 Week Low
114.35
PE Ratio
PB Ratio
4.20
PE for Sector
37.21
PB for Sector
3.95
ROE
0.23 %
ROCE
5.74 %
Dividend Yield
0.04 %
EPS
₹0.30
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
14.23 %
Net Income Growth
109.56 %
Cash Flow Change
107.60 %
ROE
108.18 %
ROCE
175.66 %
EBITDA Margin (Avg.)
40.71 %

Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
646
864
853
1,202
853
947
867
1,117
873
1,083
1,057
1,578
1,100
1,391
Expenses
585
692
658
945
813
789
786
965
830
908
899
1,136
912
1,032
EBITDA
61
172
195
258
40
158
81
152
43
175
159
443
188
359
Operating Profit %
5 %
14 %
17 %
16 %
-9 %
5 %
3 %
8 %
2 %
9 %
12 %
26 %
14 %
20 %
Depreciation
36
38
41
51
45
47
47
53
50
51
52
53
52
54
Interest
7
15
15
20
20
29
33
34
34
28
17
28
25
30
Profit Before Tax
18
119
139
187
-25
82
1
66
-41
96
90
363
112
276
Tax
5
26
27
53
0
10
5
24
0
8
18
87
27
62
Net Profit
13
91
112
151
-17
47
-2
42
-33
77
74
273
85
210
EPS in ₹
0.11
0.78
0.94
1.28
-0.14
0.40
-0.02
0.35
-0.28
0.61
0.56
2.06
0.64
1.59

Balance Sheet

Balance Sheet
2021
2022
2023
2024
Total Assets
5,757
7,371
8,042
9,551
Fixed Assets
1,627
2,439
2,602
2,612
Current Assets
1,768
2,102
2,349
3,292
Capital Work in Progress
121
405
417
533
Investments
1,592
1,630
1,747
1,708
Other Assets
2,417
2,897
3,277
4,697
Total Liabilities
1,656
2,248
2,781
2,839
Current Liabilities
1,472
1,579
1,951
2,228
Non Current Liabilities
184
669
829
611
Total Equity
4,101
5,123
5,262
6,712
Reserve & Surplus
3,106
3,937
4,068
5,389
Share Capital
995
1,186
1,193
1,323

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
146
-19
-73
175
Investing Activities
-4,383
-1,165
-435
-635
Operating Activities
35
249
72
358
Financing Activities
4,494
896
290
451

Share Holding

% Holding
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
34.79 %
34.79 %
34.79 %
34.79 %
35.02 %
35.02 %
35.02 %
35.02 %
34.95 %
34.95 %
FIIs
27.36 %
21.29 %
19.27 %
15.01 %
14.19 %
14.33 %
14.47 %
12.55 %
13.42 %
13.73 %
DIIs
24.86 %
25.28 %
24.99 %
25.49 %
25.87 %
26.06 %
27.72 %
30.17 %
30.95 %
31.81 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
12.59 %
18.25 %
20.56 %
24.32 %
24.54 %
24.21 %
22.41 %
21.89 %
20.21 %
19.07 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,777.00 4,25,929.94 38.00 49,887.17 12.06 9,648 27.35 40.28
1,462.15 1,18,825.56 25.74 26,520.66 14.17 4,155 12.95 38.47
2,534.25 1,02,885.42 48.65 10,615.63 19.57 1,942 28.89 46.80
1,192.55 1,01,290.13 18.97 28,905.40 12.36 5,578 -9.47 32.64
944.70 95,280.30 22.27 19,831.50 13.82 3,831 14.57 32.02
2,040.85 92,929.19 35.38 20,141.50 19.94 1,936 73.52 37.01
1,220.00 73,119.28 20.05 29,559.25 17.55 3,169 8.65 20.74
5,590.05 66,062.65 30.38 12,978.42 9.84 1,811 14.16 35.74
1,465.80 42,112.35 - 12,653.09 6.58 -1,831 675.84 30.08
1,571.65 39,910.21 59.43 7,829.81 22.92 529 80.05 52.38

Corporate Action

Technical Indicators

RSI(14)
Neutral
49.50
ATR(14)
Less Volatile
15.91
STOCH(9,6)
Oversold
18.55
STOCH RSI(14)
Oversold
4.36
MACD(12,26)
Bearish
-3.59
ADX(14)
Strong Trend
30.04
UO(9)
Bearish
34.65
ROC(12)
Downtrend And Accelerating
-0.75
WillR(14)
Oversold
-89.81